MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0008229
Medicate International Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.74 Cr
▼ 36% YoY
Net profit · FY 2024
₹4.88 Lakh
Net margin 2.8%
EBITDA · FY 2024
₹17.93 Lakh
EBITDA margin 10.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Medicate International Private Limited
Data last updated:
Medicate International Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140DL2015PTC280215. Its GSTIN is 07AAJCM7330B1ZQ (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Laxmi and Ashwini Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No 3013/2 – A Khasra No 69 G Floor Gali No – 19 Ranjit Nagar, New Delhi, Delhi, India – 110008.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.74 Cr, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹4.88 Lakh (net margin 2.8%) and EBITDA of ₹17.93 Lakh (EBITDA margin 10.3%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 19% over five years.
The company is associated with 1 brand: Medicate Pharma. As per MCA filings, the company has open charges of ₹1 Cr on record.
Medicate International Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0008229). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medicatepharma.com.
Company details
CIN U74140DL2015PTC280215
Registration Number 280215
Incorporation Date 14 May 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0008229
Key People
Laxmi Director Ashwini Tripathi Director Recognitions & Rankings of Medicate International
Contact details
Medicate International Private Limited's registered office is in New Delhi, Delhi. Its website is medicatepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressHouse No 3013/2 – A Khasra No 69 G Floor Gali No – 19 Ranjit Nagar, New Delhi, Delhi, India – 110008
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medicate International Private Limited, buy the company report.
Comprehensive company report
Medicate International Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Medicate International operates one associated brand: Medicate Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distributes a wide range of diversified pharmaceutical drugs. | medicatepharma.com |
Business activity
The main business activity of Medicate International is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medicate International Private Limited, buy the company report.
Financials of Medicate International Private Limited
FY 2024 filings availableMedicate International Private Limited reported revenue of ₹1.74 Cr (down 36% YoY) for FY 2024.
Revenue · FY 2024
₹1.74 Cr ▼ 36%
Net profit · FY 2024
₹4.88 Lakh margin 2.8%
EBITDA · FY 2024
₹17.93 Lakh margin 10.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 36%
3 years · compounded
▼ 20%
5 years · compounded
▼ 19%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 4%
5 years · compounded
▼ 12%
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 36% fall in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.3% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medicate International Private Limited, buy the company report.
Board of directors of Medicate International Private Limited
Medicate International has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Laxmi Also directs: W&B Health Care Private Limited | Director | 14 May 2015 | 11 Years 5 Months | Current |
| Ashwini Tripathi Also directs: W&B Health Care Private Limited, Vikeshi Microcare Foundation | Director | 14 May 2015 | 11 Years 5 Months | Current |
Peer comparison
Medicate International Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Srisahith Enterprise (OPC) Private Limited | ₹1.75 Cr (FY 2025) | 44.0% | Aruppukottai, Tamil Nadu, India | |||
| Kalpa Healthcare Private Limited | ₹1.75 Cr (FY 2024) | 4.0% | Chennai, Tamil Nadu, India | |||
| Surecare Pharma Private Limited | ₹1.74 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Nilachala Medi Point Private Limited | ₹1.74 Cr (FY 2025) | 90.0% | Bhubaneswar, Odisha, India | |||
| Medicate International Private Limitedthis company | ₹1.74 Cr (FY 2024) | ₹4.88 Lakh | 2.8% | -36.0% | New Delhi, Delhi, India | |
| Sri Vijaya Medicals Private Limited | ₹1.73 Cr (FY 2025) | 16.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Medicate International Private Limited, buy the company report.
Auditor
Medicate International Private Limited is audited by VINEET SANDESH & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINEET SANDESH & ASSOCIATES | FY 2023 | 020885N |
Shareholding
The shareholding of Medicate International Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medicate International Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Jun 2017 | 100102566 | Others | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medicate International Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medicate International Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medicate International has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCM7330B1ZQ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medicate International Private Limited, buy the company report.
Recent activity
Medicate International Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Ashwini Tripathi was appointed as Director on 14 May 2015.
AGM
Medicate International Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medicate International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 100102566 was registered on 05 Jun 2017.
Appointed
Ashwini Tripathi was appointed as Director.
Appointed
Laxmi was appointed as Director.
Incorporation
14 May 2015
Medicate International Private Limited was registered on 14 May 2015 with Roc Delhi & aged 11 years 5 months as per MCA records.
Frequently asked questions
Medicate International is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 May 2015 (11+ years old) and is registered under CIN U74140DL2015PTC280215.
Medicate International has 2 current directors:
- Laxmi - Director
- Ashwini Tripathi - Director
The latest financial statements of Medicate International on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Medicate International is 07AAJCM7330B1ZQ, registered in Delhi.
The CIN (Corporate Identification Number) of Medicate International is U74140DL2015PTC280215. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicate International was incorporated on 14 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medicate International by revenue are Srisahith Enterprise (OPC) Private Limited, Kalpa Healthcare Private Limited, Surecare Pharma Private Limited, Nilachala Medi Point Private Limited, Sri Vijaya Medicals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ashwini Tripathi was appointed as Director on 14 May 2015. Laxmi was appointed as Director on 14 May 2015.
Yes, Medicate International is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0008229).
Medicate International can be reached through the website medicatepharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Medicate International is at House No 30132 – A Khasra No 69 G Floor Gali No – 19 Ranjit Nagar, New Delhi, Delhi, India – 110008.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages